Orforglipron, an oral small-molecule glp-1 receptor agonist for obesity treatment
Thus, in patients with type 2 diabetes, combination incretin therapy is poised to provide better glycemic efficacy than treatment with a GLP-1 receptor agonist alone while maintaining a good side-effect profile with respect to avoiding hypoglycemia. As Healio previously reported, top-line data from SURPASS-4, the largest and longest trial of the program to date, also demonstrated that tirzepatide significantly reduced HbA1c and body weight compared with insulin glargine (Lantus, Sanofi) for adults with type 2 diabetes at high cardiovascular risk
While brain fog isnt a medical term, a recent study in Frontiers in Pharmacology found that malaisea general unwell feelingand fatigue rank among the top 13 complaints about semaglutide on the FDAs Adverse Event Reporting System database
Cancer Symp 51:9, 1998
In a separate published study run in 2021, fetal sex was accurately determined in 100% of 134 pregnant women at 7 weeks gestational age
lower mutation rates in N